Spiral Computed Tomography (SCT) Market Report 2026

The spiral computed tomography (sct) market size has grown strongly in recent years. It will grow from $8.98 billion in 2025 to $9.69 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to increase in chronic disease diagnosis, growth in hospital imaging capacity, rising oncology screening rates, expansion of radiology departments, early replacement of conventional ct systems.

The spiral computed tomography (sct) market size is expected to see strong growth in the next few years. It will grow to $13.24 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to growing aging population, rising demand for early detection imaging, expansion of emergency diagnostic services, increasing investment in advanced radiology, higher outpatient imaging volumes. Major trends in the forecast period include growing adoption of multi slice spiral scanners, rising use of low dose imaging protocols, expansion of three dimensional reconstruction software, increasing integration of AI assisted image analysis, higher demand for fast scan trauma imaging.

The increasing adoption of personalized medicine is expected to drive the growth of the spiral computed tomography (SCT) market in the coming years. Personalized medicine is a healthcare approach that customizes disease prevention, diagnosis, and treatment according to an individual’s genetic, molecular, and cellular characteristics. The growth of personalized medicine is fueled by advancements in genomics and molecular diagnostics, which allow treatments to be tailored to a patient’s unique genetic profile and disease traits. Spiral computed tomography (SCT) facilitates personalized medicine by offering high-resolution, three-dimensional imaging, enabling clinicians to accurately visualize specific anatomical and pathological details and thus support tailored diagnosis, treatment planning, and monitoring for each patient’s distinct condition. For example, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, a substantial increase from six approvals in 2022. Hence, the growing adoption of personalized medicine is driving the expansion of the Spiral Computed Tomography (SCT) market.

Leading companies operating in the spiral computed tomography (SCT) market are focusing on developing innovative solutions, spiral CT technology, to meet the rising demand for faster, more accurate, and lower-radiation diagnostic imaging driven by the increasing prevalence of chronic diseases and the need for efficient early detection. Spiral CT technology uses a continuously rotating X-ray tube and a moving patient table to produce detailed three-dimensional images of the body, offering faster acquisition and improved spatial resolution compared with traditional step-and-shoot CT scanners, which acquire images in discrete slices rather than a helical volume. For example, in June 2024, FUJIFILM Healthcare Americas Corporation, a US-based provider of diagnostic imaging solutions, launched the FCT iStream 128-Slice Computed Tomography System, an innovative CT scanner that integrates proprietary technologies such as HiMAR Plus for high image quality metal artifact reduction, Intelli IPV for iterative progressive reconstruction that significantly reduces image noise, IntelliODM for organ-based dose modulation, and SynergyDrive for automated workflow optimization; this compact, AI-enabled system captures up to 60 images per second, enhances diagnostic capabilities, and substantially lowers patient radiation exposure across a broad range of radiological applications, from routine body imaging to advanced cardiac CT angiography, while improving patient comfort with a wide bore design.

In July 2025, LK Metrology Ltd, a UK-based supplier of coordinate measuring machines and precision metrology solutions, acquired ProCon X-Ray GmbH for an undisclosed sum. Through this acquisition, LK Metrology sought to broaden its portfolio into industrial computed tomography (CT) and X-ray inspection technologies, enhancing its capabilities in non-destructive testing and advanced dimensional measurement for high-precision manufacturing sectors. ProCon X-Ray GmbH is a Germany-based producer of industrial CT and X-ray inspection systems utilized for internal structure analysis and quality assurance across aerospace, automotive, and electronics industries.

Major companies operating in the spiral computed tomography (sct) market are Hitachi Ltd., Siemens Healthineers AG, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Analogic Corporation, Shimadzu Corporation, Canon Medical Systems Corporation, United Imaging Healthcare Co. Ltd., Carestream Health Inc., Accuray Incorporated, Neusoft Medical Systems Co. Ltd., MinFound Medical Systems Co. Ltd., North Star Imaging Inc., Xoran Technologies LLC, Koning Corporation, Shenzhen Anke High-tech Co. Ltd., Planmed Oy, NeuroLogica Corporation, Comet Yxlon GmbH.

Tariffs are impacting the spiral computed tomography market by increasing the cost of imported imaging hardware, detector arrays, and precision x ray components. Duties on high value medical imaging systems are raising capital equipment prices for hospitals and diagnostic centers. Hardware and scanner component segments are most affected due to global supply chains. Countries dependent on imported imaging systems are facing delayed upgrades and budget constraints. Providers are renegotiating supplier contracts and extending equipment lifecycles. At the same time, tariffs are encouraging regional assembly and localized servicing capabilities. This supports domestic medical imaging ecosystems.

The spiral computed tomography (sct) market research report is one of a series of new reports that provides spiral computed tomography (sct) market statistics, including spiral computed tomography (sct) industry global market size, regional shares, competitors with a spiral computed tomography (sct) market share, detailed spiral computed tomography (sct) market segments, market trends and opportunities, and any further data you may need to thrive in the spiral computed tomography (sct) industry. This spiral computed tomography (sct) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Spiral computed tomography (SCT), also called helical computed tomography, is an advanced imaging method where the X-ray source rotates continuously around the patient as the table moves through the scanner, forming a spiral data pattern. This uninterrupted data capture allows quicker scanning and production of detailed three-dimensional images of internal body structures. It enhances image clarity and diagnostic precision by minimizing motion distortion and enabling detailed visualization of organs, tissues, and blood vessels.

The core components of spiral computed tomography (SCT) consist of hardware, software, and services. Hardware encompasses the physical imaging equipment, including scanners and associated components, used to perform spiral CT scans with high precision and speed. These solutions utilize technologies such as single-slice and multi-slice spiral computed tomography and employ detector types including ionization chamber detectors and solid-state detectors. They are applied across multiple clinical areas, including oncology, cardiology, neuroscience, pulmonology, and trauma care, and are used by end-users such as hospitals, diagnostic imaging centers, outpatient care facilities, and research institutions.

The spiral computed tomography (SCT) market consists of sales of gantry and X-ray tube assemblies, detector arrays, imaging consoles and control units, reconstruction and processing software, patient tables and positioning devices, and contrast injector systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.